Inogen (NASDAQ:INGN) Earns Buy Rating from Analysts at B. Riley
B. Riley began coverage on shares of Inogen (NASDAQ:INGN – Free Report) in a research report report published on Sunday, Marketbeat.com reports. The brokerage issued a buy rating and a $14.00 price target on the medical technology company’s stock. Several other analysts have also recently issued reports on INGN. Needham & Company LLC raised Inogen […]
B. Riley began coverage on shares of Inogen (NASDAQ:INGN – Free Report) in a research report report published on Sunday, Marketbeat.com reports. The brokerage issued a buy rating and a $14.00 price target on the medical technology company’s stock. Several other analysts have also recently issued reports on INGN. Needham & Company LLC raised Inogen […]
